Medicine and Dentistry
Fecal Microbiota Transplantation
100%
Patient
64%
Clostridium Difficile Infection
46%
Therapeutic Procedure
39%
Donor
33%
Infection
20%
Vancomycin
18%
Inpatient
16%
Infusion
15%
Gut Microbiota
14%
Species
14%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Bacterium
11%
Laboratory
11%
Inflammatory Bowel Disease
11%
Analysis
11%
Combination Therapy
10%
Ulcerative Colitis
10%
Diseases
10%
Feces
10%
Diarrhea
10%
COVID-19
9%
Implant
9%
Irritable Bowel Syndrome
8%
Child
8%
Diet
7%
Hospital
7%
Antibiotics
7%
Parasite (Microbiology)
7%
Randomized Clinical Trial
7%
Antibiotics
6%
Pseudomembranous Colitis
6%
Peptoclostridium difficile
6%
Oral Cavity
5%
Adverse Event
5%
Parasitic Disease
5%
Patient with Inflammatory Bowel Disease
5%
Diverticulum
5%
Colon
5%
Culture
5%
Gut
5%
Immunology and Microbiology
Transplantation
41%
Feces microflora
41%
Hybridization
13%
Intestine Flora
13%
Peptoclostridium difficile
11%
Inflammatory Bowel Disease
11%
Polymerase Chain Reaction
9%
Species
9%
Electric Potential
8%
Clostridium difficile
7%
Mycobacterium marinum
6%
Microflora
6%
Time
5%
Screening
5%
Candida
5%
Colitis
5%
Bacterium
5%
Pharmacology, Toxicology and Pharmaceutical Science
Clostridium Difficile Infection
26%
Intestine Flora
13%
Vancomycin
12%
Infection
12%
Feces microflora
9%
Diarrhea
9%
Rifaximin
9%
Proton Pump Inhibitor
7%
Bacterium
7%
Randomized Clinical Trial
5%
